Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Mustang Bio stock

Learn how to easily invest in Mustang Bio stock.

Mustang Bio Inc is a biotechnology business based in the US. Mustang Bio shares (MBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Mustang Bio employs 102 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Mustang Bio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MBIO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Mustang Bio stock price (NASDAQ: MBIO)

Use our graph to track the performance of MBIO stocks over time.

Mustang Bio shares at a glance

Information last updated 2022-06-23.
Latest market close$0.59
52-week range$0.56 - $3.70
50-day moving average $0.71
200-day moving average $1.47
Wall St. target price$7.20
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.77

Buy Mustang Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
Financial advice powered by relationships, not commissions.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Mustang Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Mustang Bio price performance over time

Historical closes compared with the close of $0.585 from 2022-06-30

1 week (2022-06-24) -19.92%
1 month (2022-05-31) -9.32%
3 months (2022-03-29) -47.77%
6 months (2021-12-31) -64.76%
1 year (2021-07-01) -82.59%
2 years (2020-07-01) -81.40%
3 years (2019-07-01) 3.66
5 years (2017-06-27) N/A

Mustang Bio financials

Gross profit TTM $0
Return on assets TTM -31.96%
Return on equity TTM -61.73%
Profit margin 0%
Book value $0.97
Market capitalisation $81 million

TTM: trailing 12 months

Mustang Bio share dividends

We're not expecting Mustang Bio to pay a dividend over the next 12 months.

Mustang Bio share price volatility

Over the last 12 months, Mustang Bio's shares have ranged in value from as little as $0.56 up to $3.695. A popular way to gauge a stock's volatility is its "beta".

MBIO.US volatility(beta: 1.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mustang Bio's is 1.7691. This would suggest that Mustang Bio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Mustang Bio overview

Mustang Bio, Inc. , a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-107 and MB-207, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapies for blastic plasmacytoid dendritic cell neoplasm, acute myeloid leukemia, and myelodysplastic syndrome; MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-104 CAR T for multiple myeloma and light chain amyloidosis; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clin Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH, and Minaris Regenerative Medicine GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.

Frequently asked questions

What percentage of Mustang Bio is owned by insiders or institutions?
Currently 21.028% of Mustang Bio shares are held by insiders and 25.397% by institutions.
How many people work for Mustang Bio?
Latest data suggests 102 work at Mustang Bio.
When does the fiscal year end for Mustang Bio?
Mustang Bio's fiscal year ends in December.
Where is Mustang Bio based?
Mustang Bio's address is: 377 Plantation Street, Worcester, MA, United States, 01605
What is Mustang Bio's ISIN number?
Mustang Bio's international securities identification number is: US62818Q1040
What is Mustang Bio's CUSIP number?
Mustang Bio's Committee on Uniform Securities Identification Procedures number is: 62818Q104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site